Clinical trial
Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being…
NCT00452270 · Novartis, Industry · Completed
Key facts
| NCT number | NCT00452270 |
|---|---|
| Title | Decongestant Effect, Timing of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold |
| Official title | A Double-Blind, Randomized, Parallel Group, Placebo Controlled Study, Evaluating the Decongestant Effect, Time to Onset, Duration of Effect and Impact on Sleep and General Well-Being of Xylometazoline in Subjects With a Common Cold |
| Lead sponsor | Novartis, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Common Cold |
| Intervention type | Drug |
| Interventions | Xylometazoline |
| Enrollment | 60 |
| Start date | Mar 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | Mar 27, 2007 |
| Last update posted | May 3, 2007 |
| Countries | United Kingdom |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: